Project Grant R01DK143287
- Federal Grant Award Summary New York University School of Medicine received a $843,457 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for June 30, 2030. The award funds research to evaluate and design an ABO-compatible kidney allocation policy for the U.S. organ transplantation system,...
- Federal Grant Award Summary New York University School of Medicine received a $842,633 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 24, 2025, with completion targeted for July 31, 2030. This research initiative will develop an evidence-based prehabilitation program specifically designed for kidney transplant (KT) candidates on...
- Federal Project Grant Award Summary New York University School of Medicine received a $847,371 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through July 31, 2030. The research project will develop individualized immunosuppression protocols for kidney transplant (KT) recipients by leveraging real-world clinical data...
- Federal Grant Award Summary New York University School of Medicine received a $1,721,026 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 10, 2025, through August 31, 2030, funds a comprehensive analysis of long-term health outcomes in living kidney donors (LKDs) utilizing the COSMOS dataset, which encompasses electronic...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Leland Stanford Junior University a $1.5M Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct comprehensive research on improving kidney transplant outcomes and reducing care costs through enhanced pretransplant operations. Awarded on September 15, 2025, with completion scheduled for August 31, 2029, this research...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $231,270 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a two-year research initiative extending through August 31, 2027, titled "Advancing CKD Risk Prediction: Exome-Wide Studies and...
- Federal Grant Award Summary New York University School of Medicine received a $165,899 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with completion targeted for July 31, 2030. The award funds Project ANCHOR (Addressing the Needs of Caregivers to Help Optimize Resilience), an exploratory sequential mixed methods research study...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $200,000.00 to New York University School of Medicine to conduct a case-cohort study investigating novel determinants of risk for living kidney donors. The key objectives are to: 1) use qualitative research to inform recruitment strategies and messaging to maximize participation of...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $685,605 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 15, 2025, through August 31, 2030. This research project investigates hospital-to-skilled nursing facility (SNF) care transitions for patients with end-stage kidney disease (ESKD), addressing a...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The University of Texas Southwestern Medical Center a $548,165 Project Grant effective March 3, 2025, through December 31, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates survivorship trajectories and outcomes for liver transplant (LT) recipients beyond standard graft and patient survival...
Grant Award Summary New York University School of Medicine received a $847,495 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on February 19, 2026, with completion targeted for November 30, 2030. This research initiative addresses the critical national problem of kidney non-utilization by developing and evaluating a stratified kidney allocation system designed to increase organ utilization, reduce transplant wait times, and improve outcomes for kidney transplant candidates. The project will produce expert consensus recommendations on the system's design parameters, including criteria for categorizing kidney quality levels and donor-recipient matching protocols. The deliverables include quantitative impact analyses and projections to inform policymaker decision-making regarding stratified allocation implementation, as well as comprehensive investigation of patient, care partner, and healthcare provider attitudes, perceptions, and acceptability regarding shared decision-making in kidney offer acceptance processes. By addressing current gaps in understanding how candidates would respond to obligatory but modifiable choices between accepting superior kidneys after longer waits versus non-ideal kidneys sooner, this research aims to generate evidence-based guidance for a potential policy reform that could mitigate the documented shortage of transplanted kidneys while improving clinical and equity outcomes across patient populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $847.5k | 2/19/26 |